ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC50239-50mg |
|
1440251-53-5 |
ML 315 hydrochloride
|
0 | — | |
GC50239-10mg |
|
1440251-53-5 |
ML 315 hydrochloride
|
0 | — | |
GC50238-1mg |
|
— |
PMX 53c
|
0 | — | |
GC50237-50mg |
|
1802013-08-6 |
ITH 12575
|
0 | — | |
GC50237-10mg |
|
1802013-08-6 |
ITH 12575
|
0 | — | |
GC50236-50mg |
|
— |
MS049 oxalate salt
|
0 | — | |
GC50236-10mg |
|
— |
MS049 oxalate salt
|
0 | — | |
GC50235-1mg |
|
— |
Naloxone 3-glucuronide carbonic acid salt
|
0 | — | |
GC50234-50mg |
|
862974-25-2 |
N106
|
0 | — | |
GC50234-10mg |
|
862974-25-2 |
N106
|
0 | — | |
GC50233-50mg |
|
212142-18-2 |
Vatalanib succinate
|
0 | — | |
GC50233-10mg |
|
212142-18-2 |
Vatalanib succinate
|
0 | — | |
GC50232-1mg |
|
311309-25-8 |
RFRP-1 (human)
|
0 | — | |
GC50231-100μg |
|
1233152-82-3 |
Guangxitoxin 1E
|
0 | — | |
GC50230-50mg |
|
276702-15-9 |
SB 332235
|
0 | — | |
GC50230-10mg |
|
276702-15-9 |
SB 332235
|
0 | — | |
GC50229-50mg |
|
1414376-84-3 |
VUF 11222
|
0 | — | |
GC50229-10mg |
|
1414376-84-3 |
VUF 11222
|
0 | — | |
GC50228-50mg |
|
1029521-30-9 |
NVP CXCR2 20
|
0 | — | |
GC50228-10mg |
|
1029521-30-9 |
NVP CXCR2 20
|
0 | — | |